# Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

> **NCT03458208** · PHASE1 · COMPLETED · sponsor: **Geropharm** · enrollment: 18 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Metformin
- **DRUG:** Glucophage®
- **DRUG:** Metformin
- **DRUG:** Glucophage®

## Key facts

- **NCT ID:** NCT03458208
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-14
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-03-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03458208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03458208, "Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03458208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*